Financial News
Latest News about NVO
Recent news which mentions NVO
   Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
   
  
  
  September 07, 2024
  From Motley Fool
 
   Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
   
  
  
  September 05, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 
   Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.
   
  
  
  September 05, 2024
  From Motley Fool
 
   Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?
   
  
  
  September 05, 2024
  From Motley Fool
 
   Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
   
  
  
  September 04, 2024
  From Benzinga
 From Benzinga
 
   EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
   
  
  
  September 04, 2024
  From Benzinga
 
   Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
   
  
  
  September 03, 2024
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  September 03, 2024
  From Benzinga
 
   Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate
   
  
  
  September 02, 2024
  From Benzinga
 
   Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential
   
  
  
  August 31, 2024
  From Benzinga
 
   3 No-Brainer Stocks to Buy in September
   
  
  
  August 31, 2024
  From Motley Fool
 From Motley Fool
 From Benzinga
 
   Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients
   
  
  
  August 30, 2024
  From Benzinga
 From Motley Fool
 From Motley Fool
 From Benzinga
 From Motley Fool
 
   Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates
   
  
  
  August 26, 2024
  From Benzinga
 
   Novo Nordisk Does Not Operate As Drug Cartel, CEO Defends US Pricing Of Ozempic Against Criticism Over High Drug Prices
   
  
  
  August 26, 2024
  From Benzinga
 Tickers 
   NVO
  
  
  From Motley Fool
 
   2 No-Brainer Healthcare Stocks to Buy With $1,000
   
  
  
  August 24, 2024
  From Motley Fool
 From Benzinga
 From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

 
  
 
 
 










